Granda Alacote A, Goyoneche Linares G, Castaneda Torrico M, Diaz-Obregon D, Nunez M, Murillo Carrasco A
Biomedicines. 2025; 13(1).
PMID: 39857588
PMC: 11759818.
DOI: 10.3390/biomedicines13010003.
Qiu L, Wu B
Front Cardiovasc Med. 2024; 11:1426953.
PMID: 39726943
PMC: 11669582.
DOI: 10.3389/fcvm.2024.1426953.
Fan X, Wu L, Wang F, Liu D, Cen X, Xia H
Kidney Dis (Basel). 2024; 10(6):573-587.
PMID: 39664332
PMC: 11631111.
DOI: 10.1159/000541486.
Hwang W, Lee E, Park J, Ahn S
Epidemiol Health. 2024; 46:e2024090.
PMID: 39563202
PMC: 11840418.
DOI: 10.4178/epih.e2024090.
Yu C, Zhou W, Zhou X, Zhu L, Wang T, Bao H
J Clin Hypertens (Greenwich). 2024; 26(12):1433-1440.
PMID: 39400503
PMC: 11654844.
DOI: 10.1111/jch.14913.
Six months of physical inactivity is insufficient to cause chronic kidney disease in C57BL/6J mice.
Opurum P, Decker S, Stuart D, Peterlin A, Paula V, Siripoksup P
bioRxiv. 2024; .
PMID: 39257785
PMC: 11384017.
DOI: 10.1101/2024.08.29.610415.
.
Meguellati N, Regaiguia N, Rayane T, Boulahia Y, Chiad M, Saidani M
Tunis Med. 2024; 102(7):423-428.
PMID: 38982968
PMC: 11358792.
DOI: 10.62438/tunismed.v102i7.4785.
External validation of the 2-year mortality prediction tool in hemodialysis patients developed using a Bayesian network.
Granal M, Brokhes-Le Calvez S, Dimitrov Y, Chantrel F, Borni-Duval C, Muller C
Clin Kidney J. 2024; 17(6):sfae095.
PMID: 38915433
PMC: 11195611.
DOI: 10.1093/ckj/sfae095.
Associations of mixed metal exposure with chronic kidney disease from NHANES 2011-2018.
Shi X, Wang X, Zhang J, Dang Y, Ouyang C, Pan J
Sci Rep. 2024; 14(1):13062.
PMID: 38844557
PMC: 11156859.
DOI: 10.1038/s41598-024-63858-3.
Chronic Kidney Disease in Brazil: Current Status and Recommended Improvements.
Bauer A, Elias R, Abensur H, Batista M, Jansen A, Riella M
Kidney Dis (Basel). 2024; 10(3):213-223.
PMID: 38835403
PMC: 11149994.
DOI: 10.1159/000538068.
Temporal trends in prevalence and disability of chronic kidney disease caused by specific etiologies: an analysis of the Global Burden of Disease Study 2019.
Qing X, Jiang J, Yuan C, Xie K, Wang K
J Nephrol. 2024; 37(3):723-737.
PMID: 38512378
DOI: 10.1007/s40620-024-01914-x.
Azilsartan improves urinary albumin excretion in hypertension mice.
Cao J, Zhang D, Li W, Yuan W, Luo G, Xie S
Aging (Albany NY). 2024; 16(5):4138-4148.
PMID: 38462692
PMC: 10968693.
DOI: 10.18632/aging.205271.
Peritoneal dialysis vs. hemodialysis among patients with end-stage renal disease in Iran: which is more cost-effective?.
Yousefi M, Rezaei S, Hajebrahimi S, Falsafi N, Keshvari-Shad F
BMC Nephrol. 2024; 25(1):85.
PMID: 38448887
PMC: 10916316.
DOI: 10.1186/s12882-024-03530-0.
CKD of Unknown Etiology: Is Taiwan Another Hotspot?.
Tomacruz Amante I, Lin M, Hwang S
Kidney Int Rep. 2024; 9(1):4-6.
PMID: 38312791
PMC: 10831363.
DOI: 10.1016/j.ekir.2023.11.014.
Clinical characteristics and mortality predictors among very old patients with pulmonary thromboembolism: a multicenter study report.
Zhou X, Yang Y, Zhai Z, Wang D, Lei J, Xu X
BMC Pulm Med. 2024; 24(1):26.
PMID: 38200493
PMC: 10782748.
DOI: 10.1186/s12890-023-02824-7.
The Association Among Post-hemodialysis Blood Pressure, Nocturnal Hypertension, and Cardiovascular Risk Factors.
Cho H, Kwon S, Lee S, Yang Y, Kim H, Kim S
Electrolyte Blood Press. 2023; 21(2):53-60.
PMID: 38152598
PMC: 10751209.
DOI: 10.5049/EBP.2023.21.2.53.
Association of cholesterol with hepatorenal markers and quality of life in diabetic patients before and after magnesium and potassium supplements.
Khalid S, Bashir S, Basharat S, Mehboob R, Anwar T, Hashim M
Saudi Pharm J. 2023; 31(12):101865.
PMID: 38028213
PMC: 10663893.
DOI: 10.1016/j.jsps.2023.101865.
Triglyceride-glucose index predicts future chronic kidney disease development in all populations, including normotensive and isolated diastolic hypertension.
Sakoda T, Akasaki Y, Sasaki Y, Kawasoe S, Kubozono T, Ikeda Y
Hypertens Res. 2023; 47(1):149-156.
PMID: 37989912
DOI: 10.1038/s41440-023-01507-4.
Female Reproductive Health and Contraception Use in CKD: An International Mixed-Methods Study.
Chang D, Dumanski S, Brennand E, Ruzycki S, Ramage K, Gantar T
Kidney Med. 2023; 5(10):100713.
PMID: 37719717
PMC: 10502408.
DOI: 10.1016/j.xkme.2023.100713.
Isoliensinine Attenuates Renal Fibrosis and Inhibits TGF-β1/Smad2/3 Signaling Pathway in Spontaneously Hypertensive Rats.
Yao M, Lian D, Wu M, Zhou Y, Fang Y, Zhang S
Drug Des Devel Ther. 2023; 17:2749-2762.
PMID: 37701045
PMC: 10494865.
DOI: 10.2147/DDDT.S414179.